Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Baeza Mena (Barcelona, Spain), C. Centeno Clemente (Barcelona, Spain), F. Andreo García (Barcelona, Spain), P. Serra Mitja (Barcelona, Spain), R. Tazi Mezalek (Barcelona, Spain), J. Mate Sanz (Barcelona, Spain), C. Martinez Barenys (Barcelona, Spain), E. Carcereny Costa (Barcelona, Spain), V. Margeli Cervera (Barcelona, Spain), J. Abad Capa (Barcelona, Spain). PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer. 882

Member's Comments

No comment yet.

Related content which might interest you: The comparison of clinical and pathological stages of the non-small cell lung carcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 89s Year: 2006 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Clinical features of nonsmall cell lung cancer cases Source: Eur Respir J 2002; 20: Suppl. 38, 75s Year: 2002 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Soluble non-invasive markers in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005 An analysis of EGFR expression and tumour imaging in non-small cell carcinomas of lung Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 T790M-mutation in EGFR progressive non-small cell lung cancer, role of re-biopsy and ctDNA analysis Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Early recurrence in complete resected non-small cell lung cancer patients Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Expression of ERCC1 in normal and tumor tissues in non-small cell lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Liquid biopsy for EGFR mutations in non-small cell lung cancer cases by RT-PCR Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Clinical implication of stem cell markers in N2 positive non-small cell lung cancer Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer? Source: Eur Respir J 2001; 18: Suppl. 33, 232s Year: 2001 Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancer Source: Eur Respir J 2015; 46: 1541-1543 Year: 2015 Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020